findmyKOL
Clinical trialNCT05526989RecruitingPhase 2Interventional

Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma

SponsorH. Lee Moffitt Cancer Center and Research InstituteEnrollment25Penile Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Moffitt Cancer Center

    Tampa, Florida, United States

    Jingsong Zhang, MD, PhDJuskaran Chadha, DOMonica Chatwal, MD
    Recruiting
  • Md Anderson Cancer Center

    Houston, Texas, United States

    Curtis Pettaway, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Dec 2022
Primary completion
30 Nov 2026
Completion
30 Nov 2027
Last update posted
4 Dec 2025
Registered enrollment
25
Registry id
NCT05526989
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.